PDIA3 and gastric cancer: The study of Shimoda et al. [24] showed that PDIA3 expression was an independent factor of tumor staging in gastric cancer patients, and the overall survival time of PDIA3-high cases was significantly better than that of PDIA3-low cases, especially in advanced cases.